Journal of the National Cancer Institute Advance Access originally published online on June 17, 2009
JNCI Journal of the National Cancer Institute 2009 101(13):966-967; doi:10.1093/jnci/djp128
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press.
CORRESPONDENCE |
Response: Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis
Affiliation of authors: Moffitt Cancer Center and University of South Florida, Clinical Translational Science Institute, Center for Evidence-based Medicine and Health Outcome Research, Tampa, FL)
Correspondence to: Ambuj Kumar, MD, MPH, Moffitt Cancer Center, Oncologic Sciences, Health Outcomes and Behavior, 12902 Magnolia Dr, MRC 232A, Tampa, FL 33612 (e-mail: ambuj.kumar@moffitt.org).
| The first 10% of the full text of this article appears below. |
We thank Drs Tricot and Giralt and their colleagues for their comments related to our systematic review and meta-analysis on the comparative effectiveness of single and tandem autologous hematopoietic transplantation in multiple myeloma patients. The concerns of both letters relate primarily to the inclusion criteria for the studies upon which our systematic review is based. The authors suggest that studies published as abstracts or unpublished studies that did